Latest Capital Raising News

Codeifai Limited has locked in $570,000 through a discounted share placement, aiming to fuel its digital platform growth and strategic initiatives.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Scorpion Minerals has completed detailed pre-drilling exploration at its Pharos Gold Project in Western Australia and is poised to begin RC drilling targeting multiple high-grade gold zones along a prolific shear corridor.

AdAlta Limited has successfully raised $1.1 million through a renounceable rights issue, positioning itself to advance key CAR-T licensing and immunotherapy projects. The capital injection underscores confidence from leadership and investors amid a transformative phase for the biotech company.

Tambourah Metals Ltd has announced a non-renounceable pro-rata entitlement offer to raise approximately $368,000, issuing new shares at $0.02 each with free-attaching options. The capital raise aims to fund exploration projects including Beatty Park Gold and Speewah North.

Koba Resources has announced a non-renounceable entitlement offer to raise approximately $1.14 million, aiming to fund further exploration at its promising Yarramba Uranium Project in South Australia. The offer includes new shares and attaching options, inviting eligible shareholders to participate by late June 2025.

Chariot Corporation has extended the deferral period on its convertible notes with Obsidian Global, issuing 1.75 million shares as part of the amendment. This move delays potential dilution while reinforcing investor support.

Nico Resources has raised $1.1 million through a share placement priced at a premium, aiming to accelerate development of its flagship Wingellina nickel-cobalt project and support working capital needs.

Pacific Edge has successfully raised NZ$16 million through an upsized equity placement, surpassing its initial target and setting the stage for a planned NZ$5 million Share Purchase Plan. The funds aim to accelerate clinical and commercial milestones, including regaining Medicare coverage for its cancer diagnostic tests.

ALS Limited has launched a Share Purchase Plan allowing eligible shareholders to invest up to A$30,000 in new shares at a discounted price, following a recent $350 million institutional placement.

Evolution Energy Minerals has landed a US$2 million convertible note commitment from major shareholder ARCH PCC EM SRF to support its Kudu Graphite subsidiary, aiming to accelerate development of the Chilalo Graphite Project.

Life360 has announced a $250 million convertible senior notes offering, with an option for an additional $37.5 million, aiming to bolster its balance sheet and support strategic initiatives.